RecruitingNot ApplicableNCT06400992

Investigation of Sky Automatic Technologies in Pediatrics


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

20 participants

Start Date

Dec 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The hypothesis of this research is that the AS Target setting provides the best estimate of the settings required to optimize listening in noise. As such, it is expected that speech in noise performance will be best in the AS Target condition, followed by the AS Clinic condition, and the Omni condition will be the least favourable for speech in noise performance.


Eligibility

Min Age: 6 YearsMax Age: 16 Years

Inclusion Criteria7

  • Be between 6 and 16 years of age at the time of inclusion
  • Use spoken French as their primary mode of communication
  • Ability to perform the Simplified French Matrix test in Noise
  • Bimodal group: use the Sky CI processor or be eligible for a Sky CI processor upgrade on one side and use a contralateral hearing aid
  • Bilaterally implanted group: use two Sky CI processors or be eligible for an upgrade to two Sky CI processors
  • Obtain signed consent from legal guardian(s)
  • Be enrolled in a health insurance plan or eligible for coverage

Exclusion Criteria3

  • Severe neurological pathology identified prior to inclusion identified by MRI + /- neuro-pediatric workup
  • Severe cognitive, psychiatric, or developmental disabilities identified prior to inclusion
  • Family does not understand French

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECochlear implant processor Sky CITM M90 (CI-5295)

The Sky CI available to included patients (no procedures added) offers the AutoSense Sky OS technology with the three following programming conditions possible. This three condition are fitting and evaluated in noise 6 months after inclusion: 1. Omnidirectional mode : no sound treatment 2. AS Target : Autosense is active and no modifications are made by clinician 3. AS Clinique : Autosense is active and modified by the clinician

DEVICEHearing Aid, including sound processor Phonak: Sky Link M90

The device is fitting and programmed for home especially for the purpose research at inclusion. The Clinical map parameters will be verified according to clinical routine. The Sky Link offers the AutoSense Sky OS technology with the three following programming conditions possible. This three condition are fitting and evaluated in noise 6 months after inclusion: 1. Omnidirectional mode : no sound treatment 2. AS Target : Autosense is active and no modifications are made by clinician 3. AS Clinique : Autosense is active and modified by the clinician

DIAGNOSTIC_TESTFrench simplified matrix test (FraSimat)

The FraSimat speech in noise test will be tested, 6 months before inclusion in the three different fitting configurations: omni, AS clinic, AS Target. The speech will be presented from the front, noise from 180°. Noise will be presented at a fixed level of 65 dB SPL while the speech signal will be adapted to find the 50% speech reception threshold (SRT).

BEHAVIORALAudiologist Fitting Questionnaire

After the fitting of Hearing Aid at inclusion, the audiologist will complete a questionnaire describing the fitting and justifying fitting decisions and will collect the demographic information

BEHAVIORALPatient Satisfaction Questionnaire

The patient will be giving a Patient satisfaction Questionnaire, with questions regarding device and accessory use. The audiologist will go over the instructions for filling out the questionnaire at inclusion. Patients will be asked to complete the questionnaire and return it at the next visit, 6 months after inclusion.

BEHAVIORALAutoSens Feedback Discussion Form

6 months after inclusion and fitting, the audiologist discusses the use of AS clinic with the subject and completes the AS questionnaire (questionnaire on the experience of using the processor in different listening situations).


Locations(1)

Audiophonology Unit of the Ear, Nose and Throat (ENT) Department ("Oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale") at the Necker-Enfants Malades hospital (AP-HP).

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06400992


Related Trials